Skip to main content

Rapid Micro Biosystems, Inc. (RPID)

NASDAQ: RPID · IEX Real-Time Price · USD
19.45 0.75 (3.98%)
Oct 21, 2021 2:46 PM EDT - Market open
Market Cap776.90M
Revenue (ttm)18.07M
Net Income (ttm)-51.17M
Shares Out39.95M
EPS (ttm)-1.28
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume27,504
Open18.73
Previous Close18.70
Day's Range18.65 - 19.64
52-Week Range16.34 - 27.04
Betan/a
AnalystsBuy
Price Target28.00 (+44.0%)
Est. Earnings DateNov 11, 2021

About RPID

Rapid Micro Biosystems is an innovative life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products such as biologics, vaccines, cell and gene therapies, and sterile injectables. We are leading a global transformation toward fully automated microbial quality control within pharmaceutical manufacturing. Our flagship Growth Direct platform brings the quality control lab to the manufacturing floor, unlocking the power of in-line/at-the-line...

IndustryWireless Telecommunication Services
IPO DateJul 15, 2021
CEORobert Spignesi
Employees132
Stock ExchangeNASDAQ
Ticker SymbolRPID
Full Company Profile

Financial Performance

In 2020, RPID's revenue was $16.08 million, a decrease of -2.63% compared to the previous year's $16.51 million. Losses were -$37.08 million, 75.1% more than in 2019.

Financial Statements

Analyst Forecast

According to 4 analysts, the average rating for RPID stock is "Buy." The 12-month stock price forecast is 28.00, which is an increase of 44.00% from the latest price.

Price Target
$28.00
(44.00% upside)
Analyst Consensus: Buy

News

Rapid Micro to Announce Third Quarter 2021 Financial Results on November 11, 2021

Conference Call to Discuss Results on November 12, 2021 at 5:00am Pacific Time/8:00am Eastern Time Conference Call to Discuss Results on November 12, 2021 at 5:00am Pacific Time/8:00am Eastern Time

2 days ago - GlobeNewsWire

Rapid Micro Biosystems Announces Appointment of Andy Keys as Chief Commercial Officer

LOWELL, Mass., Oct. 05, 2021 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (Rapid Micro), an innovative life sciences technology company providing mission critical automation solutions...

2 weeks ago - GlobeNewsWire

Rapid Micro Biosystems to Exhibit at the 2021 PDA Pharmaceutical Microbiology Conference on October 4-6

LOWELL, Mass., Sept. 30, 2021 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (“Rapid Micro”), an innovative life sciences technology company providing mission critical automation soluti...

3 weeks ago - GlobeNewsWire

Rapid Micro Biosystems Reports Second Quarter 2021 Financial Results and Provides Business Update and Full Year 2021 ...

Reports second quarter 2021 commercial revenue of $5.7 million, representing 135% year-over-year growth

1 month ago - GlobeNewsWire

Rapid Micro Biosystems to Announce Second Quarter 2021 Financial Results on August 26, 2021

LOWELL, Mass., Aug. 12, 2021 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission critical automation solutio...

2 months ago - GlobeNewsWire

Rapid Micro Biosystems Announces Exercise and Closing of Over-Allotment Option in Initial Public Offering

LOWELL, Mass., Aug. 04, 2021 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (“Rapid Micro”), an innovative life sciences technology company providing mission critical automation solutio...

2 months ago - GlobeNewsWire

Rapid Micro Biosystems Announces Appointment of Melinda Litherland to Board of Directors

LOWELL, Mass., Aug. 03, 2021 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (“Rapid Micro”), an innovative life sciences technology company providing mission critical automation solutio...

2 months ago - GlobeNewsWire

Rapid Micro Biosystems Announces Pricing of Initial Public Offering

LOWELL, Mass., July 14, 2021 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (“Rapid Micro”), an innovative life sciences technology company providing mission critical automation solutio...

3 months ago - GlobeNewsWire

Rapid Micro Biosystems IPO Registration Document (S-1)

Rapid Micro Biosystems, Inc. has filed to go public with an IPO on the NASDAQ.

3 months ago - SEC